News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
753,965 Results
Type
Article (44416)
Company Profile (312)
Press Release (709222)
Multimedia
Podcasts (135)
Webinars (22)
Section
Business (211241)
Career Advice (2119)
Deals (36851)
Drug Delivery (147)
Drug Development (83639)
Employer Resources (176)
FDA (16948)
Job Trends (15553)
News (357976)
Policy (34154)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2649)
Accelerated approval (55)
ADA (44)
Adcomms (30)
Allergies (196)
Alliances (51592)
ALS (226)
Alzheimer's disease (1850)
Antibody-drug conjugate (ADC) (516)
Approvals (17389)
Artificial intelligence (743)
ASCO (333)
Autoimmune disease (334)
Automation (60)
Bankruptcy (373)
Best Places to Work (11768)
BIOSECURE Act (21)
Biosimilars (236)
Biotechnology (184)
Bladder cancer (201)
Brain cancer (78)
Breast cancer (799)
Cancer (6295)
Cardiovascular disease (514)
Career advice (1809)
Career pathing (45)
CAR-T (356)
CDC (60)
Celiac Disease (3)
Cell therapy (962)
Cervical cancer (53)
Clinical research (73005)
Collaboration (2230)
Commercialization (1)
Company closure (5)
Compensation (1485)
Complete response letters (91)
COVID-19 (2827)
CRISPR (119)
C-suite (1240)
Cystic fibrosis (160)
Data (8583)
Decentralized trials (3)
Denatured (41)
Depression (175)
Dermatology (94)
Diabetes (665)
Diagnostics (7099)
Digital health (63)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (359)
Drug pricing (221)
Drug shortages (34)
Duchenne muscular dystrophy (300)
Earnings (93942)
Editorial (70)
Employer branding (21)
Employer resources (155)
Events (123464)
Executive appointments (1144)
FDA (20910)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (35)
Funding (1835)
Gene editing (248)
Generative AI (63)
Gene therapy (765)
GLP-1 (1140)
Government (4891)
Grass and pollen (7)
Guidances (416)
Healthcare (19331)
Hematology (195)
HIV (87)
Huntington's disease (62)
IgA nephropathy (112)
Immunology and inflammation (310)
Immuno-oncology (104)
Indications (210)
Infectious disease (3192)
Inflammatory bowel disease (226)
Inflation Reduction Act (14)
Influenza (140)
Intellectual property (317)
Interviews (332)
IPO (16958)
IRA (57)
Job creations (4077)
Job search strategy (1502)
JPM (65)
Kidney cancer (20)
Labor market (110)
Layoffs (601)
Leadership (43)
Legal (8427)
Liver cancer (104)
Longevity (35)
Lung cancer (832)
Lymphoma (472)
Machine learning (65)
Management (60)
Manufacturing (1158)
Marketing (1)
MASH (213)
Medical affairs (1)
Medical device (14065)
Medtech (14223)
Mergers & acquisitions (21192)
Metabolic disorders (1670)
mRNA (236)
Multiple sclerosis (195)
NASH (18)
Neurodegenerative disease (455)
Neuropsychiatric disorders (114)
Neuroscience (3488)
Neurotech (1)
NextGen: Class of 2026 (6649)
Non-profit (4586)
Now hiring (81)
Obesity (773)
Opinion (318)
Ovarian cancer (238)
Pain (281)
Pancreatic cancer (343)
Parkinson's disease (387)
Partnered (36)
Patents (636)
Patient recruitment (740)
Peanut (69)
People (61871)
Pharmaceutical (85)
Pharmacy benefit managers (35)
Phase 1 (22665)
Phase 2 (32140)
Phase 3 (24034)
Pipeline (9687)
Policy (344)
Postmarket research (2661)
Preclinical (9658)
Press Release (68)
Prostate cancer (335)
Psychedelics (60)
Radiopharmaceuticals (349)
Rare diseases (1180)
Real estate (6324)
Recruiting (72)
Regulatory (26611)
Reports (57)
Research institute (2471)
Resumes & cover letters (363)
Rett syndrome (42)
RNA editing (26)
RSV (90)
Schizophrenia (191)
Series A (311)
Series B (229)
Service/supplier (11)
Sickle cell disease (121)
Special edition (27)
Spinal muscular atrophy (170)
Sponsored (49)
Startups (3798)
State (2)
Stomach cancer (19)
Supply chain (137)
Tariffs (99)
The Weekly (92)
Vaccines (1165)
Venture capital (120)
Weight loss (506)
Women's health (135)
Worklife (20)
Date
Today (99)
Last 7 days (495)
Last 30 days (2743)
Last 365 days (30855)
2026 (15667)
2025 (30671)
2024 (35759)
2023 (40626)
2022 (51797)
2021 (56325)
2020 (54788)
2019 (47394)
2018 (35767)
2017 (33134)
2016 (32661)
2015 (38614)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (807)
Alabama (93)
Alaska (7)
Arizona (370)
Arkansas (16)
Asia (42826)
Australia (6874)
California (13943)
Canada (3935)
China (1503)
Colorado (595)
Connecticut (610)
Delaware (434)
Europe (92244)
Florida (2095)
Georgia (442)
Hawaii (3)
Idaho (63)
Illinois (1152)
India (99)
Indiana (635)
Iowa (24)
Japan (598)
Kansas (135)
Kentucky (51)
Louisiana (60)
Maine (76)
Maryland (1661)
Massachusetts (10025)
Michigan (378)
Minnesota (755)
Mississippi (6)
Missouri (147)
Montana (33)
Nebraska (30)
Nevada (149)
New Hampshire (84)
New Jersey (3653)
New Mexico (31)
New York (3654)
North Carolina (1774)
North Dakota (9)
Northern California (7021)
Ohio (416)
Oklahoma (24)
Oregon (46)
Pennsylvania (2779)
Puerto Rico (31)
Rhode Island (52)
South America (1179)
South Carolina (87)
South Dakota (2)
Southern California (5523)
Tennessee (224)
Texas (2233)
United States (49286)
Utah (413)
Vermont (2)
Virginia (356)
Washington D.C. (81)
Washington State (1116)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
753,965 Results for "cantabio pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Cantabio Pharmaceuticals Awarded Major Grant from The Michael J. Fox Foundation for the Development of a novel DJ-1 Protein Replacement Therapy for the Treatment of Parkinson’s Disease
Cantabio Pharmaceuticals, Inc. announced that The Michael J. Fox Foundation for Parkinson’s Research has awarded the Company a major grant for a project entitled “Development of Cell-penetrant DJ-1 Protein as a Therapeutic Candidate for Treatment of Parkinson’s Disease.” This grant supports the Company’s ongoing cell-penetrant DJ-1 protein replacement therapeutic program.
February 6, 2024
·
3 min read
Press Releases
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
June 3, 2026
·
4 min read
Press Releases
NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
June 3, 2026
·
5 min read
Press Releases
Merck Completes Acquisition of Terns Pharmaceuticals, Inc.
May 5, 2026
·
6 min read
Press Releases
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq
June 9, 2026
·
3 min read
Press Releases
Acurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update
May 12, 2026
·
12 min read
Biotech Bay
Cantabio Pharmaceuticals Receives Additional Grant from The Michael J. Fox Foundation for Testing Its Novel Redox DJ-1 Protein-based ELISA Platform for the Diagnosis of Parkinson’s Disease
Cantabio Pharmaceuticals, Inc. announced that The Michael J. Fox Foundation for Parkinson’s Research has awarded the Company a major grant entitled “Quantification of Cys106 of DJ-1 in Distinct Redox States in Parkinson’s Patients’ iPSC-derived Dopaminergic Neurons, Postmortem Brain Tissue and Plasma as a Potential Biomarker of Parkinson’s Disease”.
August 17, 2023
·
4 min read
Press Releases
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option
June 5, 2026
·
4 min read
Press Releases
Arna Pharma Inc. and Slate Run Pharmaceuticals Finalize Joint Venture and Launch First Brand Product
May 14, 2026
·
3 min read
Press Releases
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
May 17, 2026
·
15 min read
1 of 75,397
Next
